Virax Holdings has just released a positive
announcement regarding it's HIV drug.
Virax was trading at over 40c when an
earlier efficacy trial showed no improvement against the HIV virus and VHL plummeted to around 20c. This result appears to turn that around. At the moment it's trading at 26.5c.
I hold VHL. Do your own research before
investing.